The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Antibacterial Drugs-Global Market Insights and Sales Trends 2024

Antibacterial Drugs-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1859094

No of Pages : 107

Synopsis
Antibacterial drugs refer to the substances that can destroy or inhibit the growth of microorganism such as bacteria. Antibacterial drugs are often termed as antibiotics, and widely used in prevention and treatment of infectious dieses. Various classes of these drugs have been developed, according to the microorganism to be checked. Antibacterial drugs market is driven by increasing prevalence of infectious diseases.
The global Antibacterial Drugs market size is expected to reach US$ 52350 million by 2029, growing at a CAGR of 1.6% from 2023 to 2029. The market is mainly driven by the significant applications of Antibacterial Drugs in various end use industries. The expanding demands from the Hospital, Clinics and Others,, are propelling Antibacterial Drugs market. Cephalosporins, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Penicillins segment is estimated at % CAGR for the next seven-year period.
Increase in aged population, growing demand for efficient and affordable antibacterial drugs and increasing number of multi-drug resistant bacterial strains are some of the key factors that are driving the global antibacterial drugs market. In addition, increased prevalence of infectious diseases, that demand for development of innovative molecules or treatment are driving the antibacterial drugs market. However, factors such as rising number of generic drugs for antibacterial activities and patent expiries are restraining the growth of antibacterial market. In addition, less R&D in this field and increased market maturity are restraining the global antibacterial drugs market.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antibacterial Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antibacterial Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antibacterial Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antibacterial Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antibacterial Drugs covered in this report include Sanofi, Allergan, GSK, Merck, Pfizer, Sandoz, Teva Pharmaceuticals, Abbott and Johnson & Johnson, etc.
The global Antibacterial Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Allergan
GSK
Merck
Pfizer
Sandoz
Teva Pharmaceuticals
Abbott
Johnson & Johnson
Eli Lilly
Global Antibacterial Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antibacterial Drugs market, Segment by Type:
Cephalosporins
Penicillins
Fluoroquinolones
Macrolides
Carbapenems
Others
Global Antibacterial Drugs market, by Application
Hospital
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antibacterial Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antibacterial Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Antibacterial Drugs Market Overview
1.1 Antibacterial Drugs Product Overview
1.2 Antibacterial Drugs Market Segment by Type
1.2.1 Cephalosporins
1.2.2 Penicillins
1.2.3 Fluoroquinolones
1.2.4 Macrolides
1.2.5 Carbapenems
1.2.6 Others
1.3 Global Antibacterial Drugs Market Size by Type
1.3.1 Global Antibacterial Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Antibacterial Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Antibacterial Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antibacterial Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Antibacterial Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Antibacterial Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Antibacterial Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Antibacterial Drugs Sales Breakdown by Type (2018-2023)
2 Global Antibacterial Drugs Market Competition by Company
2.1 Global Top Players by Antibacterial Drugs Sales (2018-2023)
2.2 Global Top Players by Antibacterial Drugs Revenue (2018-2023)
2.3 Global Top Players by Antibacterial Drugs Price (2018-2023)
2.4 Global Top Manufacturers Antibacterial Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antibacterial Drugs Market Competitive Situation and Trends
2.5.1 Antibacterial Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Antibacterial Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibacterial Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Antibacterial Drugs Market
2.8 Key Manufacturers Antibacterial Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antibacterial Drugs Status and Outlook by Region
3.1 Global Antibacterial Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antibacterial Drugs Historic Market Size by Region
3.2.1 Global Antibacterial Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Antibacterial Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Antibacterial Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Antibacterial Drugs Forecasted Market Size by Region
3.3.1 Global Antibacterial Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Antibacterial Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Antibacterial Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antibacterial Drugs by Application
4.1 Antibacterial Drugs Market Segment by Application
4.1.1 Hospital
4.1.2 Clinics
4.1.3 Others
4.2 Global Antibacterial Drugs Market Size by Application
4.2.1 Global Antibacterial Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Antibacterial Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Antibacterial Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antibacterial Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Antibacterial Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Antibacterial Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Antibacterial Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Antibacterial Drugs Sales Breakdown by Application (2018-2023)
5 North America Antibacterial Drugs by Country
5.1 North America Antibacterial Drugs Historic Market Size by Country
5.1.1 North America Antibacterial Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antibacterial Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Antibacterial Drugs Sales in Value by Country (2018-2023)
5.2 North America Antibacterial Drugs Forecasted Market Size by Country
5.2.1 North America Antibacterial Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Antibacterial Drugs Sales in Value by Country (2024-2029)
6 Europe Antibacterial Drugs by Country
6.1 Europe Antibacterial Drugs Historic Market Size by Country
6.1.1 Europe Antibacterial Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antibacterial Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Antibacterial Drugs Sales in Value by Country (2018-2023)
6.2 Europe Antibacterial Drugs Forecasted Market Size by Country
6.2.1 Europe Antibacterial Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Antibacterial Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Antibacterial Drugs by Region
7.1 Asia-Pacific Antibacterial Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Antibacterial Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antibacterial Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Antibacterial Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Antibacterial Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Antibacterial Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antibacterial Drugs Sales in Value by Region (2024-2029)
8 Latin America Antibacterial Drugs by Country
8.1 Latin America Antibacterial Drugs Historic Market Size by Country
8.1.1 Latin America Antibacterial Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antibacterial Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Antibacterial Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Antibacterial Drugs Forecasted Market Size by Country
8.2.1 Latin America Antibacterial Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antibacterial Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Antibacterial Drugs by Country
9.1 Middle East and Africa Antibacterial Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Antibacterial Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antibacterial Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Antibacterial Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Antibacterial Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Antibacterial Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antibacterial Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Antibacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Antibacterial Drugs Products Offered
10.1.5 Sanofi Recent Development
10.2 Allergan
10.2.1 Allergan Company Information
10.2.2 Allergan Introduction and Business Overview
10.2.3 Allergan Antibacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Allergan Antibacterial Drugs Products Offered
10.2.5 Allergan Recent Development
10.3 GSK
10.3.1 GSK Company Information
10.3.2 GSK Introduction and Business Overview
10.3.3 GSK Antibacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GSK Antibacterial Drugs Products Offered
10.3.5 GSK Recent Development
10.4 Merck
10.4.1 Merck Company Information
10.4.2 Merck Introduction and Business Overview
10.4.3 Merck Antibacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Merck Antibacterial Drugs Products Offered
10.4.5 Merck Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Antibacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pfizer Antibacterial Drugs Products Offered
10.5.5 Pfizer Recent Development
10.6 Sandoz
10.6.1 Sandoz Company Information
10.6.2 Sandoz Introduction and Business Overview
10.6.3 Sandoz Antibacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sandoz Antibacterial Drugs Products Offered
10.6.5 Sandoz Recent Development
10.7 Teva Pharmaceuticals
10.7.1 Teva Pharmaceuticals Company Information
10.7.2 Teva Pharmaceuticals Introduction and Business Overview
10.7.3 Teva Pharmaceuticals Antibacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Teva Pharmaceuticals Antibacterial Drugs Products Offered
10.7.5 Teva Pharmaceuticals Recent Development
10.8 Abbott
10.8.1 Abbott Company Information
10.8.2 Abbott Introduction and Business Overview
10.8.3 Abbott Antibacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Abbott Antibacterial Drugs Products Offered
10.8.5 Abbott Recent Development
10.9 Johnson & Johnson
10.9.1 Johnson & Johnson Company Information
10.9.2 Johnson & Johnson Introduction and Business Overview
10.9.3 Johnson & Johnson Antibacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Johnson & Johnson Antibacterial Drugs Products Offered
10.9.5 Johnson & Johnson Recent Development
10.10 Eli Lilly
10.10.1 Eli Lilly Company Information
10.10.2 Eli Lilly Introduction and Business Overview
10.10.3 Eli Lilly Antibacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Eli Lilly Antibacterial Drugs Products Offered
10.10.5 Eli Lilly Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antibacterial Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antibacterial Drugs Industrial Chain Analysis
11.4 Antibacterial Drugs Market Dynamics
11.4.1 Antibacterial Drugs Industry Trends
11.4.2 Antibacterial Drugs Market Drivers
11.4.3 Antibacterial Drugs Market Challenges
11.4.4 Antibacterial Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antibacterial Drugs Distributors
12.3 Antibacterial Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’